Of note, the BM-derived CD11b+GR-1+ IMCs from non-tumor-bearing mice expressed a different pattern of cell surface markers than splenocyte derived MDSCs from tumor-bearing mice (Fig. S3). This evidence concerns the gene ITGAM and neoplasm.